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Abstract: In vivo monitoring of nanoparticle delivery is essential to better 
understand cellular and molecular interactions of nanoparticles with tissue 
and to better plan nanoparticle-mediated therapies. We developed a three-
dimensional  ultrasound  and  photoacoustic  (PA)  imaging  system  and  a 
spectroscopic PA imaging algorithm to identify and quantify the presence of 
nanoparticles and other tissue constituents. Using the developed system and 
approach, three-dimensional in vivo imaging of a mouse with tumor was 
performed  before  and  after  intravenous  injection  of  gold  nanorods.  The 
developed  spectroscopic  PA  imaging  algorithm  estimated  distribution  of 
nanoparticle as well as oxygen saturation of blood. Moreover, silver staining 
of  excised  tumor  tissue  confirmed  nanoparticle  deposition,  and  showed 
good correlation with spectroscopic PA images. The results of our study 
suggest that three-dimensional ultrasound-guided spectroscopic PA imaging 
can monitor nanoparticle delivery in vivo. 
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1. Introduction 
Gold  nanoparticles  have  been  considered  attractive  contrast  agents  for  photoacoustic 
molecular  imaging  [1–4],  as  well  as  therapeutic  agents  for  photothermal  therapy  [5–7], 
because of high optical absorption properties, superior biocompatibility [8] and capability of 
molecular specific targeting of the cells. Monitoring of nanoparticle delivery is essential to 
better  understand  fundamental  molecular  pathways  inside  organisms  and  to  better  plan 
nanoparticle-mediated photothermal cancer therapy [9,10]. The photoacoustic (PA) imaging 
technique can detect nanoparticles (NPs) based on 2 ways: quantitative changes of PA signals 
between pre- and post-injection of NPs and spectroscopic methods. 
Single-wavelength PA imaging has been used to detect contrast agents in live mice based 
on changes of PA signal intensity [2,11]. Unfortunately, analysis of PA signal at only one 
wavelength is prone to error because the increase of PA intensity can be caused not only by 
the  deposition  of  contrast  agents,  but  also  by  physiological  changes  (i.e.,  tumor  growth, 
angiogenesis, etc.). Moreover, when longitudinal PA imaging is performed, the repeatability 
of the imaging experiments can be another problem because PA signals are linearly dependent 
with local laser fluence, which will be changed by tumor growth and re-positioning of the 
animal  between  imaging  sessions.  Multi-wavelength  PA  imaging  (i.e.,  spectroscopic  PA 
imaging) can be a solution to overcome the problems of single-wavelength PA imaging. 
The  spectroscopic  PA  imaging  technique  mainly  relies  on  a  tissue-dependent  optical 
absorption  spectrum.  It  can,  therefore,  distinguish  different  types  of  tissue  such  as 
oxyhemoglobin,  deoxyhemoglobin,  and  lipid  [12,13].  Spectroscopic  PA  imaging  has  also 
been  used  to  detect  NPs  based  on  PA  spectrum  and  NP  absorption  spectrum  [1,14,15]. 
However, in order to utilize spectroscopic PA imaging for in vivo detection of NPs, a more 
robust imaging algorithm needs to be developed. 
In this paper, we present an in vivo spectroscopic PA imaging algorithm as well as a three-
dimensional  (3-D)  ultrasound  (US)  and  PA  imaging  system.  The  developed  system  and 
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nanorods injected into the tail vein of a mouse bearing a subcutaneous tumor. The results of 
spectroscopic PA imaging before (i.e., control) and 31 hours after the NP injection showed 
that the developed system and algorithm can detect NPs in vivo. Moreover, silver staining of 
the excised tumor tissue confirmed the NP deposition, and showed  good correlation with 
spectroscopic PA imaging results. 
2. Materials and Methods 
2.1. Nanoparticles 
PEGylated  gold  nanorods  (PEG-Au  NRs)  were  synthesized  for  this  study.  First, 
cetyltrimethylammonium  bromide  (CTAB)-stabilized  gold  nanorods  were  prepared  with  a 
seed-mediated growth method [16]. Then the CTAB was replaced by mPEG-thiol through 
ligand exchange. The prepared PEG-Au NRs were characterized by ultraviolet-visible (UV-
Vis) spectroscopy and transmission electron microscopy (TEM). The absorbance spectrum of 
PEG-Au NRs measured by UV-Vis spectroscopy is shown in Fig. 1, and compared with the 
absorption  spectra  of  deoxyhemoglobin  (Hb)  and  oxyhemoglobin  (HbO2)  reported  in 
literature [17]. The wavelength of PEG-Au NRs’ peak absorbance was about 790 nm, and the 
size of PEG-Au NRs, derived from the TEM image as shown in Fig. 1, was about 40 nm by 
10 nm. 
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Fig. 1. The absorption spectra of deoxyhemoglobin (Hb, blue dashed line) and oxyhemoglobin 
(HbO2, red dash-dotted line) [17] compared to the absorbance spectrum of the PEGylated gold 
nanorod (PEG-Au NR, green solid line) measured by UV-Vis spectroscopy. Dots on each line 
correspond to wavelengths used for spectroscopic photoacoustic imaging. The transmission 
electron microscopy (TEM) image of PEG-Au NRs is also shown. 
2.2. Mouse bearing a subcutaneous tumor 
A 3-month old immunodeficient nude mouse (Nu/Nu) weighing about 18 g was used for this 
study. Human cancer cells (A431 cell line) were subcutaneously injected on the right flank of 
the mouse. The injected cells were grown for 20 days resulting in a tumor size of about 10 
mm in diameter. Then two imaging sessions were performed: before (control experiment) and 
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vein. The amount of gold in the 200  L NP solution was 400  g. During imaging sessions, the 
mouse  was  anesthetized  with  a  combination  of  isoflurane  (0.5  ~2.0%)  and  oxygen  (0.5 
L/min). After the second imaging session, the mouse was euthanized by carbon dioxide (CO2) 
asphyxiation, and the tumor was excised for histological analysis (i.e., silver staining). All 
these procedures were performed under the animal protocol approved by Institutional Animal 
Care and Use Committee (IACUC) at The University of Texas at Austin. 
2.3. In vivo imaging system 
A 3-D US and PA imaging system developed for in vivo mouse imaging is shown in Fig. 2. A 
tunable laser system consisting an optical parametric oscillator (OPO) (PremiScan, Spectra-
Physics) pumped by Q-switch Nd:YAG laser (Quanta-Ray PRO-Series, Spectra-Physics) was 
capable of producing 7 ns pulses at 10 Hz pulse repetition frequency. The overall spectral 
range  of  the  system  was  from  400  to  2300  nm  wavelength.  For  this  study,  we  used  6 
wavelengths ranging from 740 to 840 nm with an increment of 20 nm (i.e., 740, 760, 780, 
800, 820, and 840 nm). The diameter of round-shaped Gaussian laser beams was consistently 
12  mm  for  all  wavelengths,  and  the  maximum  laser  fluence  for  all  wavelengths  was  25 
mJ/cm
2 satisfying an American National Standards Institute (ANSI) limit (i.e., ~30 mJ/cm
2) 
[18]. The pulse-to-pulse laser energy was monitored and recorded using a laser power meter 
(Nova II, OPHIR)—the power meter readings were then used to compensate for laser energy 
variation during off-line PA image reconstruction. 
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Fig.  2.  Schematic  diagram  of  the  developed  in  vivo  three-dimensional  ultrasound  and 
photoacoustic imaging system. 
#146851 - $15.00 USD Received 2 May 2011; revised 29 Jul 2011; accepted 3 Aug 2011; published 5 Aug 2011
(C) 2011 OSA 1 September 2011 / Vol. 2,  No. 9 / BIOMEDICAL OPTICS EXPRESS  2543A water tank was used for acoustic coupling between the linear array transducer and the 
skin of the mouse and for maintaining the body temperature of anesthetized mouse. Water 
temperature was kept at 37°C during experiments using a water circulation system (Isotemp 
3013H,  Fisher).  In  order  to keep  both  a  transducer-cable  connection  and  the  mouse  head 
above  water,  we  constructed  an  imaging  platform  to  diagonally  secure  the  mouse.  The 
imaging platform was connected to a 1-D motorized system (BiSlide, VELMEX) to scan the 
mouse for 3-D imaging. 
Two systems—SonixRP by Ultrasonix, Inc., and WP32 by WinProbe, Inc.—were used for 
US and PA imaging, respectively. The SonixRP system was chosen for US imaging because 
of its ability to quickly capture high quality US images with multiple focal zones, while the 
WP32 system allowed simultaneous access to 32 channel data needed for fast PA imaging. 
Both systems were interfaced with the same linear array transducer (L12/128 by Vermon, 128 
elements, 9 MHz center frequency, 5.8 MHz bandwidth) to collect either pulse-echo US or PA 
signals. For one 2-D US image, 128 beams of radiofrequency (RF) signals (i.e., beamformed 
US data) were collected using 64 transmit- and 32 receive-channels, requiring acquisition time 
of about 0.025 seconds. In PA imaging mode, 4 laser pulses were required for one full data set 
of 128 RF signals (i.e., pre-beamformed PA signals). Moreover, to enhance signal-to-noise 
ratio (SNR), 32 PA pre-beamformed RF signals were averaged requiring 128 laser pulses for 
one PA image. The acquisition time for one frame of PA image was 12.8 seconds. The PA 
image reconstruction (or, in other words, beamforming) was performed off-line. 
2.4. Spectroscopic photoacoustic imaging 
Photoacoustic imaging 
The collected PA signal was first filtered using a 128th order finite impulse response (FIR) 
bandpass filter. The cutoff  frequency of the filter  was determined based on the measured 
bandwidth of the transducer (9 MHz center frequency and 5.8 MHz bandwidth). Then the 32 
bandpass filtered PA signals from each element were averaged in order to enhance SNR. The 
PA images were reconstructed using a delay-and-sum beamforming [19]. Specifically, the 128 
PA signals were used to generate 96 scanlines or beams (i.e., beamformed data) covering a 
96-element aperture positioned in the middle of the array. A Hamming window was applied 
for aperture apodization during the beamforming. This suppressed side-lobes of the PA beam, 
enhancing  contrast-to-noise  ratio  (CNR)  while  widening  a  main  lobe,  and  thus  slightly 
degrading lateral spatial resolution. The PA beamformed RF data were down-converted by 
taking  the  absolute  values  of  Hilbert  transform  of  RF  data.  The  PA  images  were  then 
displayed using a linear scale. 
Depth- and wavelength-dependent fluence compensation of photoacoustic signal 
Assuming both stress and thermal confinements are satisfied, the PA maximum pressure, p0, 
at the pressure source can be expressed as follows [20] 
  0( , ) ( ) ( , ) ( , ), a p F λ   λ λ = Γ r r r r    (1) 
where Γ is the local (r) Grüneisen parameter,  a is wavelength (λ) dependent local (r) optical 
absorption coefficient, and F is wavelength-dependent local laser fluence. Both the optical 
absorption  coefficient  and  the  Grüneisen  parameter  are  tissue-dependent.  The  Grüneisen 
parameter is defined by the volume expansion coefficient (β), the speed of sound (vs) and the 
heat capacity at constant pressure (Cp) 
 
2
.
s
p
v
C
β
Γ =    (2) 
The distribution of the laser fluence depends on optical properties of the tissue and laser 
light delivery system (e.g., beam profile, incident laser fluence, etc.). 
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presented  in  Fig.  3  (steps  1-3).  First,  the  imaged  tissue  was  segmented  by  tissue  type. 
Specifically, skin and background tissue were identified and skin thickness was determined 
from US images (Fig. 3, step 1). Then, using Beer’s law, the fluence was estimated using a 
simple 2-D skin-tissue two-layer model (Fig. 3, step 2) 
 
( , )
0 ( , ) ( ) ,
eff F F e
  λ λ λ
− =
r r r   (3) 
where F0 is wavelength-dependent incident fluence measured by a laser power meter during 
experiments, |r| is the distance between skin and position, r, within the tissue, and  eff is both 
wavelength- and tissue-dependent effective attenuation coefficient defined as 
 
' 3 ( ), eff a a s         = +    (4) 
where  a and  
’
s are absorption and transport scattering coefficients, respectively. The optical 
properties of mouse skin and tumor were obtained from literature [21,22]. Finally, PA signal 
was  compensated  using  the  derived  fluence  map  (Fig.  3,  step  3).  Note  that  the  analysis 
described by steps 1-3 was performed for every optical wavelength resulting in wavelength- 
and depth-dependent fluence compensation of PA signal. 
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Fig. 3. Schematic diagram of the developed spectroscopic photoacoustic imaging algorithm. 
Spectral analysis 
Assuming there are three major optical absorbers in a body (i.e., oxyhemoglobin (HbO2), 
deoxyhemoglobin (Hb), and nanoparticle (NP)), the absorption coefficient of localized mouse 
tissue can be defined by the sum of absorption coefficients for HbO2, Hb, and NP in the 
region.  Note  that  the  absorption  coefficient  ( a)  is  the  product  of  the  molar  absorption 
coefficient (ε) and the molar concentration (C) of the absorber. Therefore, the wavelength-
dependent local absorption coefficient (i.e.,  a(λ,r)) can be described as 
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2 2 ( , ) ( ) ( ) ( ) ( ) ( ) ( ), a HbO HbO Hb Hb NP NP C C C   λ ε λ ε λ ε λ = + + r r r r    (5) 
where  CHbO2,  CHb,  and  CNP  are  the  molar  concentrations  [M]  of  HbO2,  Hb,  and  NP, 
respectively, and εHbO2, εHb, and εNP are the molar absorption coefficients [cm
−1M
−1] of HbO2, 
Hb, and NP, respectively. Given depth- and wavelength-dependent fluence compensation, the 
measured local PA spectrum (p0(λ,r)) can be directly related to the local absorption spectrum 
( a(λ,r)) (see Eq. (1)). Linear least squares (LLS) method can resolve the concentrations of 
multiple absorbers, and therefore distinguish tissue components [12]. Moreover, the resolved 
HbO2 and Hb concentrations can be used for estimating oxygen saturation in blood. However, 
the  LLS  method  often  predicts  negative  concentrations  due  to  imperfect  fluence 
compensations,  noise  in  the  measurements,  contribution  to  PA  signals  from  other  optical 
absorbers,  etc.  Because  a  negative  concentration  has  no  physical  meaning,  it  negates  the 
calculated concentrations of the other absorbers at that location. 
To overcome the problems of the LLS method for in vivo deep penetration imaging, we 
have developed a robust, less noise-sensitive PA spectral analysis algorithm that minimizes 
the mean square error while maintaining positive concentrations for each absorber (Fig. 3, 
step  4).  Each  molar  absorption  spectrum  (ε(λ))  of  HbO2,  Hb,  and  NP  within  the  used 
wavelength range (λ1 < λ < λ2) was first normalized as 
 
[ ]
1 2
* ( )
( ) .
max ( )
λ λ λ
ε λ
ε λ
ε λ
< <
=    (6) 
Then the local absorption spectrum ( 
’
a(λ,r)) can be described as 
 
2
' * * *
2 ( , ) [ ]( ) ( ) [ ]( ) ( ) [ ]( ) ( ), a HbO Hb NP C HbO C Hb C NP   λ ε λ ε λ ε λ = + + r r r r    (7) 
where  C[HbO2],  C[Hb],  and  C[NP]  are  the  contribution  levels  of  the  HbO2,  Hb,  and  NP 
absorption spectra. By varying C[HbO2], C[Hb], and C[NP] from 0 to 1, and setting the sum 
of them to one (i.e., 0 < C[HbO2], C[Hb], C[NP] < 1 and C[HbO2] + C[Hb] + C[NP] = 1), the 
local absorption spectrum of all possible combinations of HbO2, Hb, and NP contributions at a 
position r can be reconstructed into  
’
a(λ,r). Then  
’
a(λ,r) is normalized in order to compare it 
with the normalized local PA spectrum (i.e., p0*(λ,r)) in a mean square error (MSE) sense: 
  ( )
2 * ' *
0( , ) ( , ) . a MSE E p λ   λ   = −    
r r    (8) 
Note that local PA intensity was defined by averaging PA signals inside a kernel (500  m 
axially, 500  m laterally, and 500  m elevationally). The kernel size was selected to be larger 
than axial and lateral spatial resolutions of PA images. The values of C[HbO2], C[Hb], and 
C[NP] in Eq. (7) were numerically determined by minimizing the mean square error (MSE) of 
Eq. (8). Then minimum mean square errors (MMSEs) were used for reliability of the results. 
The main difference between our MMSE method and the LLS method is that we allow 
constraints to be placed on the solution. However, the solutions from each approach are the 
same  if  the  solution  of  the  LLS  method  already  satisfies  the  constraints.  In  addition,  the 
MMSE method is a numerical approach, and thus computationally intensive while the LLS 
method has an analytical solution, and benefits from fast computation. Therefore, we used the 
numerical method only if the solution of the LLS analysis has negative values. By combining 
both  approaches,  we  achieved  the  development  of  a  fast,  and  less  noise-sensitive 
spectroscopic PA imaging algorithm. 
In this study, the MMSE of 0.005 was used for the threshold of the results. This is quite a 
strong constraint for reasonable analysis. The contribution levels of HbO2, Hb, and NP (i.e., 
C[HbO2], C[Hb], and C[NP]) were then used for visualizing the distributions of each. In order 
to estimate oxygen saturation (SO2) of blood, the following equation was used: 
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HbO
HbO Hb
C C HbO
SO
C C C HbO nC Hb
= =
+ +
   (9) 
where n is the scaling factor defined as 
 
[ ]
2
1 2
1 2
max ( )
.
max ( )
HbO
Hb
n
λ λ λ
λ λ λ
ε λ
ε λ
< <
< <
   
=    (10) 
Note that ε*HbO2 to ε*Hb ratio is no longer the same as εHbO2 to εHb ratio (see Eq. (6)), and 
therefore a scaling factor needs to be considered to calculate the molar concentrations. 
Figure 3 summarizes the developed spectroscopic PA imaging algorithm consisting of 
depth- and wavelength-dependent fluence compensation and spectral analysis of PA signal. 
2.5. Histological analysis (silver staining) 
To confirm the result of spectroscopic PA imaging, especially concentration of NPs (C[NP]) 
after the injection, the mouse was euthanized and tumor was excised right after the second 
imaging session (i.e., 31 hours after NP injection) for histological analysis. The excised tumor 
was carefully marked for location and orientation of spectroscopic PA imaging planes. A total 
of 4 evenly distributed histological slides were made, and silver stained to identify depositions 
of gold NPs. Since silver staining has enhanced contrast to gold in bright-field microscopic 
images, we used silver staining slides to visualize the distribution of gold NPs in the tumor. 
The corresponding 2-D images of NPs in tissue (C[NP]) were compared with silver stained 
tissue slides. 
3. Results 
Comparison of linear least square (LLS) and minimum mean square error (MMSE) methods is 
presented in Fig. 4. The US image (Fig. 4(a)) was used to generate a 2-D skin-tissue two-layer 
structure for the laser fluence compensation. As an example, the compensated PA image at 
800 nm is shown in Fig. 4(b). Since the LLS method generates negative concentration values 
(Fig. 4(c)), some areas with strong PA signal are not mapped with optical absorbers (Fig. 
4(d)). By applying the developed MMSE method, however, NP concentration can be reliably 
reconstructed (Fig. 4(e)). White arrows in Fig. 4(e) indicate locations and concentrations of 
NPs  missed  by  LLS  method,  but  recovered  by  MMSE  method.  Therefore,  the  developed 
spectroscopic  PA  imaging  algorithm  based  on  MMSE  analysis  can  reconstruct  the 
concentrations of optical absorbers in the region where LLS method fails due to negative 
concentration of photoabsorbers. 
(a) (b) (c) (d) (e)
0.4
0.85
 
Fig.  4.  Comparison  between  linear  least  square  (LLS)  and  minimum  mean  square  error 
(MMSE)  methods.  Ultrasound  image  (a)  was  used  for  the  skin-tissue  segmentation.  The 
fluence compensated photoacoustic image (b) at 800 nm is shown as a reference. Spectral 
analysis based on LLS method can produce negative concentrations (c) of optical absorbers due 
to  imperfect  fluence  compensations,  noisy  measurements,  etc.  The  regions  producing  a 
negative NP concentration by LLS method get removed from the NP image. (d). However, the 
developed MMSE method can reliably reconstruct spatial distribution and concentration of NP: 
white arrows in panel (e) indicate locations where NP concentrations were recovered using 
MMSE method. 
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concentration of major photoabsorbers in mouse tumor in vivo. The 3-D US images show 
mouse tumor  morphology (i.e., tumor size and location)  as  well as overall outline of the 
mouse  body.  Tumor  growth  during  the  31  hours  between  the  two  imaging  sessions  was 
recognizable in the 3-D US images presented in Fig. 5(a) and Fig. 5(g). 
Single-wavelength PA images obtained at 800 nm (Fig. 5(b) and Fig. 5(h)) show optical 
absorption contrasts in the mouse body. Since we compensated PA signals based on local 
fluence changes estimated from a 2-D skin-tissue two-layer model, the color intensity on the 
images is proportional to the optical absorption of tissue (assuming that Grüneisen parameters 
of tissues are the same, see Eq. (1)). Within the tumor region, the PA signal distribution 
before and after the NP injection is significantly different. The increased PA signal generation 
is most likely due to NP deposition in the tumor. However, such a conclusion must be verified 
because PA signal increase  could also be due to tumor growth and angiogenesis over 31 
hours, or slight changes in the US and PA system setup and positioning of the mouse. 
The spectroscopic PA imaging analysis shows the Hb, HbO2, and NP contributions to the 
PA signal. As expected, significant increase of NP concentration in the tissue was observed by 
comparing  the  C[NP]  images  before  and  after  NP  injection  (Fig.  5(f)  and  Fig.  5(l), 
respectively). Clearly, plenty of NPs injected through tail vein accumulate at the tumor region. 
Moreover, Hb concentration is shown in tail vein area (Fig. 5(k)) which indirectly proves the 
validity of the developed spectroscopic PA image reconstruction algorithm. In addition, using 
Eq. (9) and estimates of C[Hb] and C[HbO2], oxygen saturation (SO2) of the blood can also be 
calculated (Fig. 5(c) and Fig. 5(i)). 
Four cross-sections of tumor, indicated by dotted lines in the photograph of the mouse 
(Fig. 6(a)), were analyzed for correlation between PA-derived images and histological slides. 
Overall, the distribution of NPs in C[NP] images (Fig. 6(b)) and silver stain in histological 
slides (Fig. 6(c)) is well correlated. For example, the first and second cross-sections of the 
tumor  have  much  fewer NPs than cross-sections 3 and 4—both C[NP] images and silver 
stained slides indicate the same trend. The enlarged regions of silver stained slides (Fig. 6(d) 
and Fig. 6(e)) clearly show NP accumulation at the tumor. 
SO2 C[NP]
PA800 C[Hb]
US C[HbO2]
SO2
PA800
US
C[NP]
C[Hb]
C[HbO2]
c
Before NP Injection After NP Injection (31 hours)
0.15
0.85
0.15
0.85
0.15
0.85
0.4
0.85
x
y
z
(a)
(b)
(c)
0
1
a
.
u
.
(d)
(e)
(f)
(g)
(h)
(i)
(j)
(k)
(l)
0.15
0.85
0
1
a
.
u
.
0.15
0.85
0.15
0.85
0.4
0.85
 
Fig. 5. Three-dimensional ultrasound images (panels a,g), photoacoustic images (panels b,h), 
and PA-derived oxygen saturation images (SO2, panels c,i), and images of oxyhemoglobin 
(C[HbO2], panels d,j), deoxyhemoglobin (C[Hb], panels e,k), and nanoparticle (C[NP], panels 
f,l) concentration before and 31 hours after tail vein injection of PEGylated gold nanorods into 
tumor bearing mouse. PA and PA-derived images are shown with ultrasound images in the 
background. Oxygen saturation was calculated using the concentrations of oxyhemoglobin and 
deoxyhemoglobin. Furthermore, anatomical features of the tumor (i.e., tumor size and location) 
are better shown in rotating 3-D images: ultrasound (panel g, Media 1), 3-D photoacoustics 
(panel h, Media 2), oxygen saturation (panel i, Media 3), and nanoparticle concentration (panel 
l, Media 4). 
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Fig. 6. (a) Photograph of the mouse with dotted lines indicating the approximate location of 
imaging  planes  and  corresponding  histological  slides.  (b)  PA-derived  maps  of  NP 
concentration displayed over the ultrasound images of the tumor. (c) Silver stained tissue slides 
where gray to black colors indicate presence of NPs. The enlarged areas of silver stained slides 
are shown in panels (d) and (e). 
4. Discussion 
Spectroscopic PA imaging algorithm incorporating depth- and wavelength-dependent fluence 
compensation  and  hybrid  LLS/MMSE  analysis  (Fig.  3)  was  developed  and  demonstrated 
using  3-D  US  and  PA  in  vivo  imaging  (Fig.  2)  of  tumor  bearing  mouse  injected  with 
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using silver staining of the excised tumor tissue. 
Before  NP  injection,  spectroscopic  PA  imaging  should  detect  no  NPs.  However,  very 
small concentrations of NPs in a few locations were observed in image before the injection of 
NPs (Fig. 5(f)). Several factors may have an influence here. For example, it was assumed that 
PA signal is due to three types of optical absorbers: HbO2, Hb, and NPs. However, other 
absorbers may also be present resulting in some false positive. Noise in the measurements (or 
low signal-to-noise ratio of PA signal) can also result in incorrect analysis of optical absorbers 
contributing to PA signal. In addition, imperfect fluence compensations can cause spectral 
mismatch between the compared and reconstructed spectra. 
The depth- and wavelength-dependent fluence compensation of PA signal can be further 
improved. In this work, we could not fully compensate wavelength-dependent local fluence 
changes due to the lack of information about optical properties of mouse tumor at different 
wavelengths. For more accurate fluence-dependent PA compensation, optical properties of 
various tissues at different wavelengths, measured independently and summarized to a look-
up table, may be used. In addition, more sophisticated models, such as a 2-D or even a 3-D 
multi-layer model with incident beam specifications (e.g., beam diameter and intensity profile, 
incident angle, etc.), can improve local fluence estimation using a Monte Carlo simulation 
[23,24]. 
The developed spectroscopic PA imaging system and algorithms can identify NP delivery 
in vivo. The NPs that we used in the current studies were not specifically targeted to cancer 
cells. Therefore, the main mechanism of delivery was the enhanced permeability and retention 
(EPR) effect. However, the approach presented here can be applied to monitor the delivery of 
NPs and the temporal and spatial interactions of molecular specific targeted NP with tissue 
[25,26]. 
5. Conclusion 
We  have  developed  a  more  robust  and  less  noise-sensitive  spectroscopic  PA  imaging 
algorithm  based  on  minimum  mean  square  error (MMSE). The  3-D  US  and PA  imaging 
system and developed algorithm were used for monitoring the delivery and accumulation of 
PEGylated  gold  nanorods  which  were  intravenously  injected  into  the  mouse  bearing  a 
subcutaneous tumor.  After the injection, spatial distribution of NPs  within the tumor  was 
successfully  imaged  using  the  US  and  PA  imaging  system  and  MMSE  algorithm. 
Furthermore, NPs were reliably distinguished from the blood. Moreover, silver staining of 
tissue slices confirmed deposition of NPs in the tumor. Good correlation of NP distribution 
between histological slides and spectroscopic PA images was also demonstrated. The results 
of our study suggest that spectroscopic PA imaging can be used for monitoring the delivery 
and spatial distribution of plasmonic NPs in vivo. 
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